trending Market Intelligence /marketintelligence/en/news-insights/trending/eiUhil1FZpnjWEEggkyAxw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Canature Q3 profit falls YOY

COVID: What’s the bottom line: Credit Impact of COVID-19 on US Municipals


Broadcast deal market recap 2020 – relatively good results in a challenging year


2021 Global Private Equity Outlook


EMEA Deal-Making Muted in Q4 2020, With No Mega Deals in Sight

Canature Q3 profit falls YOY

Canature Health Technology Group Co. Ltd. said its third-quarter normalized net income was 4 fen per share, a decline from 4 fen per share in the prior-year period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 16.4 million yuan, a decline from 16.7 million yuan in the prior-year period.

The normalized profit margin declined to 9.6% from 15.6% in the year-earlier period.

Total revenue rose 58.6% on an annual basis to 170.0 million yuan from 107.2 million yuan, and total operating expenses grew 67.4% on an annual basis to 146.4 million yuan from 87.5 million yuan.

Reported net income increased 6.7% year over year to 25.3 million yuan, or 6 fen per share, from 23.7 million yuan, or 6 fen per share.

As of Oct. 25, US$1 was equivalent to 6.78 yuan.